Treatment of bipolar depression with carbamazepine: Results of an open study

Dilsaver, Steven C.; Swann, Swann C.; Chen, Yuan Who; Shoaib, Arif M.; Joe, Brooks; Krajewski, Kenneth; Gruber, Nelson P.; Tsai, Yafei

doi:10.1016/s0006-3223(96)00339-3

Cited by 58 publications

(21 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Clinically, much has been written regarding the complicated management of mixed states (Montgomery et al 2000;Freeman and McElroy 1999). Mixed episodes are more common in women, typically respond poorly to lithium (Freeman and McElroy 1999), and are characterized by particularly high rates of suicide (Dilsaver et al 1996), substance abuse (Himmelhoch and Garfinkel 1986), and anxiety (Swann et al 1993). Interestingly, recent data shows that the prevalence of mixed episodes increases during the course of bipolar illness for women, but not for men (Kessing 2008).…”

Section: Discussionmentioning

confidence: 99%

Dysfunctional Attitudes, Attributional Styles, and Phase of Illness in Bipolar Disorder

et al. 2008

View full text Add to dashboard Cite

Whereas an abundance of studies have been devoted to the study of cognitive vulnerability in unipolar depression, comparatively less is known regarding the cognitive styles of patients with bipolar disorder. This study examined the cognitive styles of 395 of the first 500 bipolar patients enrolled in the NIMH Systematic Treatment Enhancement Program for Bipolar Disorder as a function of mood state at study entry. Patients completed diagnostic and mood assessments and two measures of cognitive style: The Dysfunctional Attitudes Scale (DAS) and the Attributional Style Questionnaire (ASQ). Patients in mixed episodes exhibited significantly more negative dysfunctional attitudes and negative attributional styles than euthymic patients and significantly more dysfunctional attitudes than manic/hypomanic patients. The implications of these findings are discussed in relation to episode vulnerability, moodstate dependency of cognitive style, and cognitivebehavioral treatment.

show abstract

Section: Discussionmentioning

confidence: 99%

Dysfunctional Attitudes, Attributional Styles, and Phase of Illness in Bipolar Disorder

et al. 2008

View full text Add to dashboard Cite

show abstract

“…There is also a wealth of information describing chemotherapeutic treatment of bipolar depression that does not specify BPI or BPII illness (38)(39)(40)(41). Due to the increased time spent in the depressive phase of the illness, these studies may ultimately have a bearing on the treatment of patients with BPII.…”

Section: Pharmacotherapy Of Patients With Bpii: Current Resultsmentioning

confidence: 99%

Bipolar II Disorder: Current and Future Treatment Options

El‐Mallakh

Weisler

Townsend

et al. 2006

Annals of Clinical Psychiatry

View full text Add to dashboard Cite

The most efficacious agents are likely those with bimodal stabilizing properties, such as lithium, carbamazepine, and quetiapine. In fact, on the strength of favorable efficacy data obtained in patients with major depressive symptoms accompanying bipolar disorder, quetiapine recently became the first agent to be indicated by the FDA for monotherapeutic use in the treatment of bipolar depression, including BPII depression. Aside from the aforementioned agents, lamotrigine also shows promise in the treatment of BPII.

show abstract

“…43 46,[53][54] ). ECT: It is a good treatment for acute episode (Small et al, 55 Dilsaver et al 47,51 ). Devanand et al 56 comparing bipolar subjects in mania versus depression, versus MS, found good response in the 3 groups, but MS patients had longer hospitalization and needed a higher number of applications than bipolar depressed patients, a discordant finding from Ciaparelli et al's.…”

Section: T T T T Treatment Reatment Reatment Reatment Reatmentmentioning

confidence: 99%